University Of Otago 1
1. Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
2. Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
3. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
4. Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
5. Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinsons Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)
6. The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
7. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
8. Diminishing benefits of urban living for children and adolescents’ growth and development
9. Author Correction: Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance (Nature Communications, (2022), 13, 1, (7251), 10.1038/s41467-022-34312-7)
10. Author Correction: Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance (Nature Communications, (2022), 13, 1, (7251), 10.1038/s41467-022-34312-7)
11. Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance
12. Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance
13. Author Correction: Setting a baseline for global urban virome surveillance in sewage (Scientific Reports, (2020), 10, 1, (13748), 10.1038/s41598-020-69869-0)
14. Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores
15. Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores
16. TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populations
17. TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populations
18. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
19. Unveiling the global urban virome through wastewater metagenomics
20. Unveiling the global urban virome through wastewater metagenomics
21. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants
22. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
1